BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li J, Guo C, Wu J. The Agonists of Peroxisome Proliferator-Activated Receptor-γ for Liver Fibrosis. Drug Des Devel Ther 2021;15:2619-28. [PMID: 34168433 DOI: 10.2147/DDDT.S310163] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang L, Zhang H, Gu J, Xu W, Yuan N, Sun J, Li H. Glabridin inhibits liver fibrosis and hepatic stellate cells activation through suppression of inflammation and oxidative stress by activating PPARγ in carbon tetrachloride-treated mice. International Immunopharmacology 2022;113:109433. [DOI: 10.1016/j.intimp.2022.109433] [Reference Citation Analysis]
2 del Río C, Ruiz-pino F, Prados ME, Fiebich BL, Tena-sempere M, Muñoz E. Cannabidiol markedly alleviates skin and liver fibrosis. Front Pharmacol 2022;13:981817. [DOI: 10.3389/fphar.2022.981817] [Reference Citation Analysis]
3 Omanovic Kolaric T, Kizivat T, Mihaljevic V, Zjalic M, Bilic-Curcic I, Kuna L, Smolic R, Vcev A, Wu GY, Smolic M. Liraglutide Exerts Protective Effects by Downregulation of PPARγ, ACSL1 and SREBP-1c in Huh7 Cell Culture Models of Non-Alcoholic Steatosis and Drug-Induced Steatosis. Curr Issues Mol Biol 2022;44:3465-80. [PMID: 36005135 DOI: 10.3390/cimb44080239] [Reference Citation Analysis]
4 Wang C, Shi Y, Wang X, Ma H, Liu Q, Gao Y, Niu J. Peroxisome Proliferator-Activated Receptors Regulate Hepatic Immunity and Assist in the Treatment of Primary Biliary Cholangitis. Front Immunol 2022;13:940688. [DOI: 10.3389/fimmu.2022.940688] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Lin X, Meng X, Song Z, Lin J. Peroxisome proliferator-activator receptor γ and psoriasis, molecular and cellular biochemistry. Mol Cell Biochem 2022. [PMID: 35348980 DOI: 10.1007/s11010-022-04417-0] [Reference Citation Analysis]
6 Wang S, Liang Y, Dai C. Metabolic Regulation of Fibroblast Activation and Proliferation during Organ Fibrosis. Kidney Dis (Basel) 2022;8:115-25. [PMID: 35527985 DOI: 10.1159/000522417] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Cano-Martínez A, Bautista-Pérez R, Castrejón-Téllez V, Carreón-Torres E, Pérez-Torres I, Díaz-Díaz E, Flores-Estrada J, Guarner-Lans V, Rubio-Ruíz ME. Resveratrol and Quercetin as Regulators of Inflammatory and Purinergic Receptors to Attenuate Liver Damage Associated to Metabolic Syndrome. Int J Mol Sci 2021;22:8939. [PMID: 34445644 DOI: 10.3390/ijms22168939] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]